N. Martínez-Banaclocha

发表

Early distant relapse after optimal local control in locally advanced rectal cancer

J. Ruíz-Macia, J. Gallego-Plazas, Francisco Menarguez-Pina, 2008, International seminars in surgical oncology : ISSO.

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

M. Lejeune, M. Sánchez-Beato, V. Sánchez-Margalet, 2021, Journal for ImmunoTherapy of Cancer.

Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel)

V. Calvo, M. Provencio, D. Rodríguez-Abreu, 2021, Current oncology.

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).

N. Viñolas, B. Massuti, M. Provencio, 2019, Lung cancer.

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data

J. Bosch-Barrera, B. Massuti, M. Provencio, 2021, BMC cancer.

Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group

V. Calvo, M. Provencio, D. Rodríguez-Abreu, 2018, Leukemia & lymphoma.

Converter Phenotype: A New Profile That Is Not Exclusive to Taxanes

T. Jiménez-Rodriguez, N. Martínez-Banaclocha, Amparo Burgos-San José, 2022, Frontiers in Allergy.

Malignant Peripheral Nerve Sheath Tumor With Osseous Heterologous Differentiation in Uncommon Locations (Heart and Retropharynx)

E. Arana, I. Machado, M. Chust, 2016, International journal of surgical pathology.

SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)

V. Calvo, M. Provencio, M. Llanos, 2023, Clinical and Translational Oncology.

Randomized phase II trial (RENO): Efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC)—SLCG 10/02.

N. Viñolas, M. Provencio, R. Peñas, 2016 .

CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma

M. Sánchez-Beato, D. Rodríguez-Abreu, D. J. García-Domínguez, 2024, Frontiers in immunology.